12 | DTSS lod.23 w/ 20dma | znewcar1 | 12/29/2023 11:42:37 AM |
11 | $DTSS 24% v6,2M c.676 f33,696M H.73 gapNcrap S.55 | znewcar1 | 08/17/2023 4:58:11 PM |
10 | $DTSS 66% v12,3M c1.14 f33,696M H1.14 | znewcar1 | 08/07/2023 10:46:42 PM |
9 | HOD2.3 @2.1 S2 Thin over 3.5 | znewcar1 | 07/21/2022 2:16:12 PM |
8 | DTSS 38% v42,6M c3.2 f21,4M H4.29 | znewcar1 | 07/12/2021 4:30:24 PM |
7 | DTSS 23% v4,9M c3.31 f21,4M preMH3.7 | znewcar1 | 05/10/2021 10:07:27 PM |
6 | DTSS 49% v84,4M c3.55 f20,9M gapNgo H5.75 then | znewcar1 | 01/14/2021 4:15:40 PM |
5 | DTSS 58% v56,8M c3.08 f20,9M preMH8.38 O and fell | znewcar1 | 08/03/2020 4:16:06 PM |
4 | DTSS 26% v2,8M c2.4 f20,9M preMH@3.3 S2.11 | znewcar1 | 04/01/2020 9:43:50 PM |
3 | DTSS 22% v5,6M c3.20 f20M | znewcar1 | 02/12/2020 4:47:18 PM |
2 | DTSS 48% v3,3M c2.7666 f20M H1.99 then 30min | znewcar1 | 01/30/2020 4:14:37 PM |
1 | DTSS 274% v13M c3.34 f20M H 7.39 S2.66 morning | znewcar1 | 10/15/2019 4:27:18 PM |
Recent Articles
- Bioinformatics Market Growth Forecast: Major Trends and Drivers
- Understanding Major Holdings Notification for Investors
- Macy’s, Inc. Reports Impressive Third Quarter Financial Performance
- Roots Canada Achieves Strong Q3 Financial Performance
- Investigation of Patterson Companies: Fair Value Concerns
- Palantir Launches Warp Speed Program to Boost Manufacturing
- Innovations in Psychiatry: Findings from Seaport Therapeutics
- New Resource Website by Chemical Insights for WUI Fire Safety
- Gameday Men's Health Launches Expanded Services in Canada
- Understanding Low Testosterone: Impact on Men's Moods
- ReposiTrak Expands Network with 50 New Diverse Suppliers
- OXIO Partners with AT&T to Transform Telecom Services
- Essential Security Tips for a Happy and Safe Holiday Season
- Ververica Enhances Global Impact Through Innovative Partnerships
- Empowering Parents: Navigating Youth Mental Health Together
- Seaport Therapeutics Showcases Phase 1 Progress of SPT-300
- Exciting Developments Coming with the 2025 Mitsubishi Outlander
- Wynn Resorts Enhances Investor Relations with New Leaders
- Revolutionizing Genetic Treatments: nChroma Bio Emerges Stronger
- Exploring the Future of Advanced Air Mobility with Eve and Signature
- Veradermics Secures $75 Million for Hair Loss Treatment Trial
- Surge in Demand for Non-Associated Cellulose Rheology Modifiers
- Natural Beta Carotene Market Forecast: 4.4% Growth Ahead
- Multiparameter Patient Monitoring Market Growth and Trends
- Mobix Labs Set for Fourth Quarter Earnings Call in December
- Collaboration to Boost Cancer Immunotherapy with PLEX Tech
- Evergold Corp. Reports Promising Antimony Drill Results
- Collaborative Carbon Capture Efforts from CarbonQuest and Carbfix
- Falco Resources Elects New Directors and Finalizes Debt Deals
- Adams Clinical Expands Psychiatry Research with New Partnership
- CareDx Teams Up with TC BioPharm for Innovative Clinical Trials
- Candel Therapeutics Reports Promising Phase 3 Results for CAN-2409
- Octapharma Enhances Supply Chain Efficiency with Kinaxis
- Boralex Secures $538 Million for Major Energy Storage Project
- IISc and Ittiam Systems Forge Partnership in AI Innovation
- Rafael Holdings Shows Resilience in Q1 Fiscal 2025 Results
- Enhancing Electronic Warfare: Pacific Defense's New AI Contract
- Simply Good Foods Prepares to Share Q1 Financial Insights
- Satellos Takes Significant Step in DMD Treatment with SAT-3247
- Monte Rosa's New Licensing Deal with Novartis: A Game Changer
- Bloomreach Commits to Community Service with Pledge 1% Initiative
- New Advances in Treating HR-positive Breast Cancer Revealed
- ExxonMobil's Vision for 2030: Driving Sustainable Growth
- Tilray Expands Festive THC Beverage Offerings with XMG and Mollo
- Bio-Path Holdings Advances BP1001-A for Diabetes and Obesity
- Mongolian Mining Corporation Joins OTCQX for Greater Reach
- Fiduciary Trust Company Welcomes Puneet Nevatia as COO
- Ocugen CEO Set to Discuss Innovations at Rare Disease Summit
- Strategic Partnership: ZEDRA and Gryphon Enhance Fund Solutions
- Cognyte Shows Strong Growth in Third Quarter FY 2025 Results